Literature DB >> 12388237

Botulinum neurotoxin A attenuates release of norepinephrine but not NPY from vasoconstrictor neurons.

Judy L Morris1, Phillip Jobling, Ian L Gibbins.   

Abstract

We examined effects of botulinum neurotoxin A (BoNTA) on sympathetic constrictions of the vena cava and uterine artery from guinea pigs to test the role of soluble NSF attachment protein receptor (SNARE) proteins in release of the cotransmitters norepinephrine (NE) and neuropeptide Y (NPY). Protein extracts of venae cavae and uterine arteries showed partial cleavage of synaptosomal associated protein of 25 kDa (SNAP-25) after treatment in vitro with BoNTA (50-100 nM). The rising phase of isometric contractions of isolated venae cavae to field stimulation at 20 Hz, mediated by NE acting on alpha-adrenoceptors, was reduced significantly by 100 nM BoNTA. However, sustained sympathetic contractions mediated by NPY were not affected by BoNTA. In uterine arteries, noradrenergic contractions to 1-Hz stimulation were almost abolished by BoNTA, and contractions at 10 Hz were reduced by 50-60%. We conclude that SNARE proteins are involved in exocytosis of NE from synaptic vesicles at low frequencies of stimulation but may not be essential for exocytosis of NPY and NE from large vesicles at high stimulation frequencies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12388237     DOI: 10.1152/ajpheart.00477.2002

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  17 in total

1.  Differential involvement of N-type calcium channels in transmitter release from vasoconstrictor and vasodilator neurons.

Authors:  Judy L Morris; Daina I Ozols; Richard J Lewis; Ian L Gibbins; Phillip Jobling
Journal:  Br J Pharmacol       Date:  2004-03-01       Impact factor: 8.739

2.  Comparison of ischemic preconditioning and BotulinumA Toxin injection for the prevention of ischemia-reperfusion injury in musculocutaneous flaps

Authors:  Handan Derebaşınlıoğlu; Anil Demİröz; Yağmur Aydin; Hakan Ekmekçi; Özlem Balci Ekmekçi; Övgü Aydin; Levent Cankorkmaz
Journal:  Turk J Med Sci       Date:  2020-10-22       Impact factor: 0.973

3.  [Effect of botulinum toxin type B on residual limb sweating and pain. Is there a chance for indirect phantom pain reduction by improved prosthesis use?].

Authors:  K-U Kern; M Kohl; U Seifert; T Schlereth
Journal:  Schmerz       Date:  2012-04       Impact factor: 1.107

Review 4.  Rationale for use of onabotulinum toxin A (BOTOX) in chronic migraine.

Authors:  P Barbanti; G Egeo; L Fofi; C Aurilia; S Piroso
Journal:  Neurol Sci       Date:  2015-05       Impact factor: 3.307

Review 5.  Botulinum toxins--cause of botulism and systemic diseases?

Authors:  H Böhnel; F Gessler
Journal:  Vet Res Commun       Date:  2005-05       Impact factor: 2.459

6.  Prevention of unfavourable effects of cigarette smoke on flap viability using botulinum toxin in random pattern flaps: An experimental study.

Authors:  Hikmet Karayel; Burak Kaya; Muzaffer Caydere; Ahmet Terzioğlu; Gürcan Aslan
Journal:  Plast Surg (Oakv)       Date:  2015       Impact factor: 0.947

Review 7.  Future aspects of botulinum neurotoxins.

Authors:  K R Aoki
Journal:  J Neural Transm (Vienna)       Date:  2007-06-08       Impact factor: 3.575

8.  Modification of blood vessel diameter following perivascular application of botulinum toxin-A.

Authors:  Peter B Arnold; Chris A Campbell; George Rodeheaver; Wyndell Merritt; Raymond F Morgan; David B Drake
Journal:  Hand (N Y)       Date:  2009-02-05

9.  Botulinum Toxin in the Treatment of Vasopressor-associated Symmetric Peripheral Gangrene.

Authors:  Jenna R Stoehr; Aaron M Kearney; Jonathan P Massie; Jason H Ko; Gregory A Dumanian
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-05-21

Review 10.  Bacterial toxins and the nervous system: neurotoxins and multipotential toxins interacting with neuronal cells.

Authors:  Michel R Popoff; Bernard Poulain
Journal:  Toxins (Basel)       Date:  2010-04-15       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.